Evidence map›Paper›PMID 27861348›Full record

ReviewMedicine2016

Central nervous system nocardiosis in Queensland: A report of 20 cases and review of the literature.

Nastaran Rafiei, Anna Maria Peri, Elda Righi, Patrick Harris, David L Paterson

Erratum issuedOpen access · goldAbstract readCase ReportsReview
In one paragraph

Review in Medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 26 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 3 pooled it
9.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 3 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Clinical Characteristics and Treatment Outcome of Central Nervous System Nocardiosis: A Systematic Review of Reported Cases.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2022
    Pooled it
  2. Frontiers in cellular and infection microbiology · 2021
    Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Frontiers in medicine · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Nocardiosis in Japan: a Multicentric Retrospective Cohort Study.Antimicrobial agents and chemotherapy · 2022
    Article
  14. Estradiol AggravateFrontiers in immunology · 2022
    Article
  15. Article
  16. Article
  17. BMJ case reports · 2020
    Article
  18. Article
  19. Review
  20. Multiple brain abscesses due to Nocardia spp. in an immunocompetent patientBiomedica : revista del Instituto Nacional de Salud · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Nastaran RafieiMonash Medical Centre, Melbourne, VIC, Australia Department of Biomedical and Clinical Sciences Luigi Sacco, III Division of Infectious Diseases, Luigi Sacco Hospital, University of Milan, Milan, Italy The University of Queensland, UQ Centre for Clinical Research, Royal Brisbane & Women's Hospital, Herston, QLD, Australia Infectious Diseases Division, Santa Maria della Misericordia University Hospital, Udine, Italy Department of Microbiology, Pathology Queensland, Royal Brisbane & Women's Hospital, Herston Wesley Medical Research, Auchenflower, QLD, Australia.
Anna Maria Peri
Elda Righi
Patrick Harris
David L Paterson
Center for Effective Philanthropy · USRoyal Brisbane and Women's Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nocardia infection of the central nervous system (CNS) is an uncommon but clinically important disease, often occurring in immunocompromised individuals and carrying a high mortality rate. We present 20 cases of microbiologically proven CNS nocardiosis diagnosed in Queensland from 1997 to 2015 and review the literature from 1997 to 2016.Over 50% of cases occurred in immunocompromised individuals, with corticosteroid use posing a particularly significant risk factor. Nine (45%) patients were immunocompetent and 3 had no comorbidities at time of diagnosis. Nocardia farcinica was the most frequently isolated species (8/20) and resistance to trimethoprim-sulfamethoxazole (TMP-SMX) was found in 2 isolates. Overall, 35% of our patients died within 1 year, with the majority of deaths occurring in the first month following diagnosis. Interestingly, of the 7 deaths occurring at 1 year, 6 were attributed to N farcinica with the seventh isolate being unspeciated, suggesting the virulence of the N farcinica strain.

Indexed as

Central Nervous System Bacterial InfectionsNocardia InfectionsAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedQueenslandRetrospective Studies

Identifiers

PMID27861348
PMCPMC5120905
OpenAlexW2549154438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.